Elanco Animal Health Incorporated has announced it is to collaborate with Novozymes A/S on identifying and developing new nutritional health products and tools to help manage dairy cows’ and beef cattle microbiome, reduce gut inflammation, and control infections, and simultaneously reducing the need for antibiotics.
Elanco Animal Health’s EVP, Innovation, Regulatory and Business Development, Aaron Schacht, said: “Nutritional health is an exciting platform that will define the next generation of feed additives to improve the health and performance of food animals. This collaboration expands our growing nutritional health capability into cattle and underscores Elanco’s commitment to bring producers innovative alternatives to antibiotics, while preserving the health and welfare of the animal. The world leading research, development and production capabilities from Novozymes, combined with Elanco’s global commercial presence, is a great match and together we will bring innovative solutions to meet diverse customer and consumer needs.”
“Elanco and Novozymes to partner on Nutritional Health Innovation “
Novozymes’ VP, Animal Health & Nutrition, Susanne Palsten Buchardt, said: “We are excited to collaborate with Elanco to develop nutritional health products for dairy cows and beef cattle production that can improve sustainability in the industry. The collaboration is an important step in our efforts to deliver sustainable solutions for better lives in a growing world.”